Clopra and Cyramza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopra (metoclopramide hydrochloride) and Cyramza (ramucirumab). Common drug interactions include lung neoplasm malignant among females and febrile neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Clopra and Cyramza. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Cyramza?

Cyramza has active ingredients of ramucirumab. eHealthMe is studying from 4,052 Cyramza users. Check the latest studies of Cyramza.

On Jul, 05, 2026

15 people who take Clopra and Cyramza together, and have interactions are studied.

What are the common drug interactions of Clopra and Cyramza, by gender? *:

female:

Lung neoplasm malignant (cancer tumour of lung)
Back pain
Decreased immune responsiveness
Drug ineffective
Flushing (the warm, red condition of human skin)
Hyperhidrosis (abnormally increased sweating)
Hypoxia (low oxygen in tissues)
Malignant neoplasm progression (cancer tumour came back)
Myelosuppression (a decrease in the production of blood cells)
Nausea (feeling of having an urge to vomit)

male:

Febrile neutropenia (fever with reduced white blood cells)
Pneumonia
Vertigo
Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
Death
Drug eruption (adverse drug reaction of the skin)
Gastric cancer (stomach cancer)
Interstitial lung disease
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Osteomyelitis (infection of bone)

What are the common drug interactions of Clopra and Cyramza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Death

50-59:

Colitis (inflammation of colon)
Back pain
Drug ineffective
Flushing (the warm, red condition of human skin)
Hyperhidrosis (abnormally increased sweating)
Hypoxia (low oxygen in tissues)
Malignant neoplasm progression (cancer tumour came back)
Nausea (feeling of having an urge to vomit)
Retching (strong involuntary effort to vomit)

60+:

Pneumonia
Febrile neutropenia (fever with reduced white blood cells)
Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
Drug eruption (adverse drug reaction of the skin)
Gastric cancer (stomach cancer)
Interstitial lung disease
Decreased immune responsiveness
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Myelosuppression (a decrease in the production of blood cells)
Osteomyelitis (infection of bone)

What are the existing conditions these people have? *

Nausea (feeling of having an urge to vomit): 4 people, 26.67%
Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 26.67%
Oesophageal Squamous Cell Carcinoma (cancer that begins in flat cells lining the oesophagus): 3 people, 20.00%
Pneumonia: 3 people, 20.00%
Gastric Cancer (stomach cancer): 3 people, 20.00%
Diarrhea: 3 people, 20.00%
Metastases To Bone (cancer spreads to bone): 3 people, 20.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 13.33%
Constipation: 2 people, 13.33%
Cancer Pain: 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and Cyramza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously